The People's Perspective on Medicine

Super Immune Therapy Gave One Woman Her Life Back

A special immune therapy using a patient's own T-cells was able to reverse Ms. Perkins' metastatic breast cancer and return her to health. Will it work for others?

An experimental immune therapy conducted on a single breast cancer patient has captured a great deal of attention this week. The 49-year-old woman, Judy Perkins, had metastatic breast cancer that had spread throughout her body. The disease had not responded to a variety of previous treatments, and her doctors expected her to only live a few more months.

Personalized Immune Therapy:

Then, researchers at the National Cancer Institute initiated a brand new form of immune therapy (Zacharakis et al, Nature Medicine, June 4, 2018). They harvested specific immune cells from her tumors. These tumor-infiltrating lymphocytes, or TILs, were encouraged to multiply in the laboratory.

While the immune cells were growing outside her body, the clinicians gave Ms. Perkins one of the new immunotherapy drugs called pembrolizumab (Keytruda). This checkpoint inhibitor modified her immune system so that when her own natural T-cells (the TILs) were re-injected into her body they could attack the tumors. That is precisely what they did. More than three years later she is still alive and well with no signs of breast cancer. She has gone back to her active outdoor lifestyle, including a kayak race around the state of Florida.

Will This Kind of Super Immune Therapy Help Other Cancer Patients?

Researchers hope they will be able to repeat this very personalized treatment for other patients. At this point, however, that goal is uncertain. Widespread clinical trials of this type of very personalized immune therapy are a long way off. Two other women who underwent the TIL treatment at the same time as Ms. Perkins did not survive.

Such treatments are likely to be very expensive. Some cancer patients are already taking a different but related treatment called CAR-T (for chimeric antigen receptor T-cell therapy). FDA-approved CAR-T treatments can cost hundreds of thousands of dollars.

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
4.7- 21 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies. .
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.

Showing 4 comments
Comments
Add your comment

It’s sad that these new cancer treatments are only for the well-to-do as the regular, everyday person will never be able to afford them.

How should such treatments be paid for? The government? In that case, how would the patient to be treated be selected? Let the wealthy pay! If treatments are successful, prices will come down.

My husband developed lung cancer in 2015. In 2017 it spread to his brain. After 3 brain surgeries it has returned to his chest and side of his face. He was put on Chemo and Keytruda. After 4 infusions it was determined that the chemo was not working, and only Keytruda was continued. As of 6/11/18 it appears the disease is still progressing in the lymph nodes around his lungs. According to his doctors, “Sometimes, it just doesn’t work.” I have been told by doctors that Adenocarcinoma is a cancer that does not go away. We will continue to fight as long as he is able to, but I’m not expecting a miracle.

Could this immune therapy and pembrolizumab help someone who has had Stage 3 Colon Cancer AND a “Very Rare and Very aggressive” (Harvard Medicine’s words) type of ovarian cancer? April scan showed no tumors, but I go back to Duke June 27 for another scan.

* Be nice, and don't over share. View comment policy^